Beijing Winsunny Pharmaceutical CO.LTD (601089) — Free Cash Flow Generation Index

Latest as of December 2024: 0.43x

Beijing Winsunny Pharmaceutical CO.LTD (601089) has a Free Cash Flow Generation Index of 0.43x as of December 2024. Free cash flow of CN¥299.23 Million represents 0% of operating cash flow (CN¥690.75 Million). Explore Beijing Winsunny Pharmaceutical CO.LTD capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

0.43x
Free Cash Flow / Operating CF

Free Cash Flow

CN¥299.23 Million
CNY

Operating Cash Flow

CN¥690.75 Million
CNY

Capital Expenditures

CN¥391.52 Million
CNY

Beijing Winsunny Pharmaceutical CO.LTD Free Cash Flow Generation Index (2020–2024)

Historical FCF Generation Index trend for Beijing Winsunny Pharmaceutical CO.LTD across 5 annual periods. For the full cash flow conversion analysis, see 601089 cash generation efficiency.

Annual Free Cash Flow Generation for Beijing Winsunny Pharmaceutical CO.LTD (2020–2024)

Year-by-year Free Cash Flow Generation Index for Beijing Winsunny Pharmaceutical CO.LTD. Check Beijing Winsunny Pharmaceutical CO.LTD investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Year FCG Index Free Cash Flow (CNY) Operating CF Capital Expenditures YoY Change
2024 0.43x CN¥299.23 Million CN¥690.75 Million CN¥391.52 Million ▲ +26.9%
2023 0.34x CN¥189.82 Million CN¥555.90 Million CN¥366.08 Million ▼ -57.0%
2022 0.79x CN¥524.36 Million CN¥659.76 Million CN¥135.40 Million ▲ +25.3%
2021 0.63x CN¥335.05 Million CN¥528.02 Million CN¥192.97 Million ▲ +12.7%
2020 0.56x CN¥217.69 Million CN¥386.65 Million CN¥168.96 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).